East Ventures

East Ventures is one of the most influential early-stage firms in Southeast Asia, and its position in the Indonesian and broader regional ecosystem is roughly analogous to what some of the larger Bay Area seed funds occupy in the US. The firm writes $1M-$5M checks across seed, Series A, and Series B, operates out of Jakarta with strong relationships across the region, and has been a consistent backer of category-defining technology companies in Southeast Asia. Healthcare sits inside that broader ambition rather than as a specialty practice.

The declared sub-verticals are digital health and AI/ML in healthcare. In practice the firm has been active in telehealth, healthcare marketplaces, care delivery technology adapted to Southeast Asian patient populations, healthcare IT for the underbuilt regional provider infrastructure, and AI applications inside healthcare and adjacent enterprise contexts. The firm is generally less active in therapeutics or in pure US-style consumer wellness, and more active in companies that build for the structural realities of Southeast Asian healthcare systems where digital infrastructure is being constructed rather than retrofitted.

Check sizes of $1M-$5M and stage breadth across seed through Series B let East Ventures operate as a lead or co-lead at multiple early stages and follow on through subsequent rounds. Geographically the focus is Indonesia and Southeast Asia, with selective engagement on cross-border rounds where regional companies are scaling outward. The firm has cultivated relationships with international and regional follow-on investors who participate in Series B and later rounds for Southeast Asian companies, and that network is part of what founders are accepting on the cap table.

The team is built around investors and operators with deep Southeast Asian technology and venture experience. Diligence tends to be founder-centric and regionally informed, with attention to the practical realities of building in markets where regulation, payment infrastructure, and consumer behavior differ substantially from US norms. Founders should expect engagement that is more hands-on than passive seed-stage venture, particularly on hiring, regional expansion, and the move from local product-market fit to multi-country scale.

For founders, the practical read is that East Ventures is the natural early lead for Southeast Asian digital health and healthcare AI companies, particularly those scaling from Indonesia into the broader region. It is less useful for US-only companies or for founders who want a generalist tech investor without regional context. The engagement style is concentrated and supportive, with real time spent on operational and strategic questions and follow-on fundraising. Founders building healthcare technology in Southeast Asia and looking for a firm that can lead early rounds and stay through Series B while connecting them to international syndicates will find East Ventures the most credible regional option for that role.